EXErcise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Treatment for Cancer

Purpose

This protocol seeks to analyze patient outcomes of the standard of care, monitored group exercise regimen of high-load resistance training and functional exercises with compound movements under close supervision on individuals who have been treated for cancer.

Condition

  • Cancer

Eligibility

Eligible Ages
Between 20 Years and 89 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Age 20-89 years 2. Women of child-bearing potential must verbally confirm lack of pregnancy prior to enrollment. They should also consent to use adequate contraception during the course of the study. 3. Participants must be determined capable of engaging in resistance training by exercise personnel and/or study PI 4. Participants must complete an assessment by EOC staff and be determined safe to engage in the workout regimen by the study exercise personnel. 5. Individuals not deemed safe to participate in the standard EOC exercise program will be referred to physical therapy or elsewhere

Exclusion Criteria

  1. Severe arthritic, joint, cardiovascular, or musculoskeletal condition that would interfere with exercise program

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
General cancer patients All patients undergoing treatment for cancer on an exercise regimen
  • Other: Dose escalated resistance training
    All individuals will be engaging in resistance training during and/or after their cancer treatment
Head and neck cancer patients All patients undergoing treatment for head and neck cancer on an exercise regime
  • Other: Dose escalated resistance training
    All individuals will be engaging in resistance training during and/or after their cancer treatment
Colorectal cancer patients All patients undergoing treatment for colorectal cancer on an exercise regime
  • Other: Dose escalated resistance training
    All individuals will be engaging in resistance training during and/or after their cancer treatment
Pancreatic cancer patients All patients undergoing treatment for pancreatic cancer on an exercise regime
  • Other: Dose escalated resistance training
    All individuals will be engaging in resistance training during and/or after their cancer treatment
Metastatic breast cancer patients All patients undergoing treatment for metastatic breast cancer on an exercise regime
  • Other: Dose escalated resistance training
    All individuals will be engaging in resistance training during and/or after their cancer treatment

Recruiting Locations

AHN CI Exercise Oncology and Resiliency Center
Pittsburgh, Pennsylvania 15202
Contact:
Colin E Champ, MD, CSCS
412-734-7605
colin.champ@ahn.org

More Details

Status
Recruiting
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

Study Contact

Samantha Campbell
(412) 330-6151
samantha.campbell@ahn.org